Study on the diagnosis and treatment strategy of neurofibromatosis type 2 based on evidence-based medicine
Latest Information Update: 04 Dec 2020
At a glance
- Drugs Bevacizumab (Primary)
- Indications Neurofibromatosis 2
- Focus Therapeutic Use
- 04 Dec 2020 New trial record